IreneWapnirMDFACS

General Surgery • Palo Alto, CA

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Director of Breast Fellowship Program

Join to view full profile

Dr. Wapnir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wapnir's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94304
Phone+1 650-723-4000

Fax+1 650-736-1663

Education & Training

Rutgers Robert Wood Johnson Medical SchoolFellowship, Breast Surgical Oncology, 1988
Lincoln Medical and Mental Health CenterResidency, Surgery, 1980 - 1985
Autonomous Metropolitan University XochimilcoClass of 1980

Certifications & Licensure

CA State Medical License 2001 - 2026
NJ State Medical License 1987 - 2005
NY State Medical License 1984 - 2005
MD State Medical License 1982 - 1995
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014, 2018
America's Top Doctors for Cancer Castle Connolly, 2011-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer Start of enrollment: 2002 Jul 01
Completed
Phase 3
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study Start of enrollment: 2000 Nov 01
Completed
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample Start of enrollment: 2000 Oct 01
Completed
Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT Start of enrollment: 2008 Feb 01
Terminated
Early Phase 1
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
SPY Intra-Operative Angiography & Skin Perfusion in Immediate Breast Reconstruction w/ Implants Start of enrollment: 2011 Jun 01
Completed
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers Start of enrollment: 2010 Jul 01
Withdrawn
Not Applicable
Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer Start of enrollment: 2012 Jul 01
Completed
Phase 2
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

378 citations
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua Brody, Weiyun Z. Ai, Debra K. Czerwinski, James A. Torchia, Mia A. Levy
Journal of Clinical Oncology. 2010-10-01
1816 citations
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn, Robert W. Cho, Neethan A. Lobo, Tomer Kalisky, Mary Jo Dorie
Nature. 2009-04-09
10 citations
Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.
Barbara L Smith, Kelly K Hunt, David Carr, Peter W Blumencranz, E Shelley Hwang
NEJM Evidence. 2023-07-01

Journal Articles

Matching for Fellowship Interviews
Marc L Melcher, Irene Wapnir, JAMA

Press Mentions

Stanford Surgeons Innovate New Biological Breast ImplantsDecember 2nd, 2019
Ralph Greco, Pioneering Advocate of Work-Life Balance for Surgery Trainees, Dies at 76April 3rd, 2019
Matching for Fellowship InterviewsSeptember 21st, 2018
Join now to see all